| Literature DB >> 36207708 |
Xu Wang1, Ming Gu1, Xueqin Gao1, Xiang Xiong1, Nanxi Wang1, Qiuqi Li1, Miaomiao Ge1, Miao Luo1, Yu Zhang1,2, Xiaoli Hua3,4, Chen Shi5,6.
Abstract
BACKGROUND: Pharmacy intravenous admixture service (PIVAS) center has emerged as an important department of hospital as it can improve occupational protection and ensure the safety and effectiveness of intravenous infusions. However, medication errors were considered to be a significant challenge in PIVAS, so information-intelligence technologies were introduced to optimize the management of PIVAS. Our article summarized the application of information-intelligence technologies in PIVAS of a large third-class A hospital in China, and provided an example for PIVAS in other hospitals at home and abroad.Entities:
Keywords: Increase efficiency; Information-intelligence technologies; PIVAS; Prescription review; Reduce errors
Mesh:
Year: 2022 PMID: 36207708 PMCID: PMC9540049 DOI: 10.1186/s12913-022-08580-4
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.908
Fig. 1The daily workflow diagram of PIVAS. *Gray indicates optimized procedures involving intelligent technologies
Fig. 2The interface of the double prescription-checking of PIVAS
Fig. 3The Quick Check Manual for Intravenous medications book including guidelines for prescription reviewing
Examples of prescription-checking rules for intravenous drugs
| Type | Irrational prescriptions | Prescription-checking rules and warnings |
|---|---|---|
| Wrong solvent | Lansoprazole for injection/30 mg + 5% GS/100 mL Carboplatin injection/0.4 g + 10% GS/250 mL Homoharringtonine injection/2 mg + 0.9% NS/100 mL | 0.9% NS only 5% GS 250—00 mL only 5%or10%GS 250–500mlL |
Hepatocyte growth-promoting factor injection/120 mg + 0.9%NS/250 mL | GS only | |
| Dacarbazine injection/0.6 g + 0.9% NS/250 mL | 5% GS 250–500 mL only | |
| Incompatibility | Vitamin C injection/2 g + calcium aspartate injection/1.5 g Dexamethasone injection/3 mg + cefazedone sodium injection/0.5 g + 5% GS/100 mL | Incompatible Incompatible |
| Vitamin C injection/2 g + riboflavin sodium phosphate injection | Affectthetherapeutic effect | |
| Inappropriate concentration | Ribavirin injection/500 mg + 0.9% NS/250 mL 10% potassium chloride injection/10 mL + invert sugar injection/250 mL | ≤ 1 mg/mL ≤ 3 mL/100 mL |
| Etoposide injection/150 mg + 0.9% NS/250 mL | ≤ 0.4 mg/mL | |
| Inappropriate dosage | Propacetamolhydrochlorideinjection/4 g + 0.9% NS/100 mL Vinpocetine injection/60 mg + GS/250 mL | Adults (and children over 15 years old): 1–2 g/dose Adults: 20–30 mg/dose |
ademetionine1,4-butanedisulfonate injection/1.5g + 5% GS/250 mL | Adults: 0.5–1 g/dose | |
| Route of administration | Mouse nerve growth factor injection/18 μg + 0.9% NS/100 mL Thymopentin injection/40 mg + 0.9% NS/100 mL | Intramuscular injection Hypodermic injection |
Fig. 4Interface for pharmacists of prescription-checking rules in PIVAS
Prescription-checking rules for infusion volume
| Type of solvent (generic name) | Specifications(mL) | Maximum dosingvolume of solvent (mL) |
|---|---|---|
| 0.9% NS/5% GS | 50 | 20 |
| 0.9% NS/5% GS | 100 | 30 |
| 0.9% NS/5% GS | 250 | 60 |
| 0.9% NS/5% GS | 500 | 100 |
| 10% GS | 250 | 50 |
| GNS | 500 | 100 |
| Fructose injection | 250 | 50 |
| Invert sugar injection | 250 | 50 |
| Invert sugar and electrolytes | 500 | 100 |
| Sodium acetate ringer’s injection | 500 | 100 |
| Multiple electrolytes | 500 | 80 |
| Carbohydrates and electrolytes | 500 | 100 |
Fig. 5Warning message for excessive infusion volume
Amount of solvent requirements
| Drug | Infusion time | Solvent volume |
|---|---|---|
| Gemcitabine | 30 min | l00–250 mL |
| Docetaxel | 60 min | 150–250 mL |
| Cyclophosphamide | ≤ 3 h | ≤ 250 mL |
| Lobaplatin | ≤ 4 h | ≤ 250 mL |
Fig. 6Warning of inappropriate infusion specification
Fig. 7Infusion label with special markings and warnings
Common types of irrational medical orders and the rate of success intervention
| Group | Number of medical orders | Number of irrational medical order | Rate of irrational medical orders | Number of interventions | Success rate of intervention |
|---|---|---|---|---|---|
| 1 | 709,040 | 16,488 | 2.33% | 14,162 | 85.89% |
| 2 | 687,656 | 11,446 | 1.66% | 11,338 | 99.06% |
Fig. 8The intelligent labeling machine is used for infusions labelling
Comparison of efficiency and accuracy between manual and automatic Labeling
Fig. 9Intelligent intravenous medicine compounding robots
Fig. 10The intelligent intravenous compounding robots are used for cytotoxic drug admixing
Comparison of efficiency and error rate between intelligent and manual compounding of intravenous chemotherapy
Fig. 11The PIVAS staff operating the intelligent sorting machine
Fig. 12The PIVAS intelligent logistics robots delivering infusions to inpatient wards